2026-10-25
Revolve Group, clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
NAS100 26,990 +1.35%
S&P 7,377 +0.31%
GOLD $4,075 −0.94%
BTC $75,818 +0.09%
VIX 25.64 −9.01%
latest tape · as of 04:01 UTC
The Screen · Consumer Cyclical · Internet Retail
Revolve Group, Inc.
RVLV · the NYSE · USD · Market cap $1.4B · 1,664 employees
Revolve Group, Inc.
Not yet scored18.53 USD
Price as of 6 Nov 2026Daily close, not a live quote
Screened 2026-11-06 · the tape above runs as of 04:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price18.53 USD at the 6 Nov 2026 close
- Our value readUndervalued vs our fair value, as of 6 Nov 2026
- Our regime readMarkdown, as of 7 Nov 2026
- Ethical screenNot yet scored
- OptionsOpen interest leans to puts (put/call 455.73)
- Last reviewed6 Nov 2026 (2 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
PRICE · ONE YEAR
Our fair-value range: $19.80 to $31.59, base estimate $27.47 (screen dated 2026-11-06).
- Trend Markdown
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 455.73, read 2026-11-07
- Ethical screen not yet scored
Price18.53 USD
Fair value27.47
Ethical score70.0/100
Value readUndervaluedas of 6 Nov 2026
Our investment reviews on this name
2026-10-11Read Accumulation21.21-12.6% to today Markdown gives way to Accumulation after an 8% slide in 4 weeks
2026-09-12Read Markdown22.98-19.4% to today ✓Markup gives way to Markdown after an 8% slide in 4 weeks
2026-08-12Read Markup24.88-25.5% to today Distribution gives way to Markup after a 21% rise in 6 weeks
2026-07-02Read Distribution20.63-10.2% to today ✓First review on file: Distribution
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
The full research record, in depth, below
This name holds its markdown label.
Revolve Group, Inc. holds its Markdown at $18.53. Elevated stress, defensive posture warranted, held for 100 days.
| Phase | Markdown · caution |
| Quantitative state | Elevated stress, defensive posture warranted, held for 100 days |
| Price at the screen | $18.53 |
| Valuation | 20.70 trailing · 16.79 forward price to earnings |
| Values screen | Not scored · score 70.0 |
| Beta | 1.63 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 4.24% | Below 33% | Interest-bearing debt is just 4.2% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 40.37% | Below 49% | Money owed to the company is 40.4% of assets, under the 49% limit. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
Revolve Group, clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-11-07. It updates when the underlying figures move, and past reads are kept below.
2026-09-24
Clears
Revolve Group, clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 4%, inside the ~33% line, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
What the Numbers Say It Is WorthThe Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 6 Nov 2026: it trades at roughly a 33% discount to our $27.47 fair value, 20.40% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-06 screen. The gold marker is the market price at the same screen. A 32.5% discount to the base estimate.
Third-party analyst targets: 13 covering, consensus Buy. The average target sits +62% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere our models see it going: fair-value estimate $27.47, with a range of $19.80 to $31.59, dated to the 2026-11-06 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsInfluencer fashion platform faces a tight valuation
Revolve sits at the centre of how Gen Z discovers clothes, with influencers steering sales across its REVOLVE and FWRD sites much like a digital marketplace that never closes. Revenue is expanding at 16 percent and the ethical screen is cleared, yet the shares trade just 2 percent below our fair value with a forward multiple of 23.2 times and an opportunity rating of none.
The business earns a 5 percent profit margin and 13 percent return on equity, numbers that are respectable but not exceptional for a consumer cyclical exposed to shifting tastes and heavy competition. Thirteen analysts see a median target of 28 dollars, yet the slim margin of safety leaves little room for execution slips or a slowdown in discretionary spending.
Fashion cycles can turn quickly, and thin margins offer scant protection when growth moderates or marketing costs rise. The unknown moat adds further uncertainty around long-term pricing power. Analysis, not advice.
| Forward P/E | 16.8xfairly priced for its growth rate |
| Trailing P/E | 20.7xa premium valuation |
| EPS, trailing | 0.92 |
| EPS, forward | 1.13 |
| Revenue growth | +20.4%strong top-line growth |
| Profit margin | 4.8%barely profitable |
| Return on equity | 12.7%a solid return on shareholder capital |
| FCF yield | -0.64% |
| Debt to equity | 0.08minimal debt: a conservative balance sheet |
| Current ratio | 2.61comfortably covers its short-term bills |
| Beta | 1.63much more volatile than the market |
| Short interest, float | 0.12% |
| 52-week range | 17.35 - 31.68 |
| Market cap | $1.4B |
| Employees | 1,664 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeRVLV trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
2026-11-03
Accumulation $22.43
+0.0% Entry 17
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (14 analysts) rates it buy, with a mean price target of $29. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-02
Accumulation $22.43
+0.0% Entry 16
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (14 analysts) rates it buy, with a mean price target of $29. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-01
Accumulation $22.43
+0.8% Entry 15
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 0.8% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (14 analysts) rates it buy, with a mean price target of $29. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-31
Accumulation $22.26
+0.0% Entry 14
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (14 analysts) rates it buy, with a mean price target of $29. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-30
Accumulation $22.26
+0.0% Entry 13
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (14 analysts) rates it buy, with a mean price target of $29. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-29
Accumulation $22.26
-1.9% Entry 12
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 1.9% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (14 analysts) rates it buy, with a mean price target of $29. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-28
Accumulation $22.69
+0.0% Entry 11
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (14 analysts) rates it buy, with a mean price target of $29. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-27
Accumulation $22.69
+0.0% Entry 10
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (14 analysts) rates it buy, with a mean price target of $29. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25
Accumulation $22.69
-2.2% Entry 9
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 2.2% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (14 analysts) rates it buy, with a mean price target of $29.
2026-10-18
Accumulation $23.21
+9.4% Entry 8
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 9.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (14 analysts) rates it buy, with a mean price target of $29.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Ralph Lauren (RL) Earnings Expected to Grow: Should You Buy? Yahoo Finance · 10d ago
- Earnings Preview: Revolve Group (RVLV) Q3 Earnings Expected to Decline Yahoo Finance · 12d ago
- 1 of Wall Street’s favorite stocks worth investigating and 2 we find risky Yahoo Finance · 12d ago
- REVOLVE Opens New Store at Aventura Mall, Expanding Its Physical Retail Presence Yahoo Finance · 16d ago
- 3 Russell 2000 stocks with questionable fundamentals Yahoo Finance · 17d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
LQDTLiquidity Services, Inc.
HEPSD-Market Elektronik Hizmetler ve Ticaret A.S.
JMIAJumia Technologies AG
REREATRenew Inc.
ZKHZKH Group Ltd ADR
ASOMYASOS Plc
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $18.63 | +9.2% | · | $1,092 | +9.2% |
| 2 months | $24.56 | -17.2% | · | $828 | -17.2% |
| 3 months | $22.84 | -11.0% | · | $891 | -11.0% |
| 6 months | $28.57 | -28.8% | · | $712 | -28.8% |
| 1 year | $21.82 | -6.8% | · | $932 | -6.8% |
| 2 years | $17.72 | +14.8% | · | $1,148 | +14.8% |
| 3 years | $15.80 | +28.7% | · | $1,287 | +28.7% |
| 5 years | $57.40 | -64.6% | · | $354 | -64.6% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever RVLV does next, these words stay.
Membership
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.